Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.

Maffey-Steffan J, Scarpa L, Svirydenka A, Nilica B, Mair C, Buxbaum S, Bektic J, von Guggenberg E, Uprimny C, Horninger W, Virgolini I.

Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):740. doi: 10.1007/s00259-019-04660-6.

PMID:
31863137
2.

Amplification of 7p12 Is Associated with Pathologic Nonresponse to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.

Pichler R, Lindner AK, Compérat E, Obrist P, Schäfer G, Todenhöfer T, Horninger W, Culig Z, Untergasser G.

Am J Pathol. 2020 Feb;190(2):442-452. doi: 10.1016/j.ajpath.2019.10.018. Epub 2019 Dec 13.

3.

The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.

Maffey-Steffan J, Scarpa L, Svirydenka A, Nilica B, Mair C, Buxbaum S, Bektic J, von Guggenberg E, Uprimny C, Horninger W, Virgolini I.

Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):695-712. doi: 10.1007/s00259-019-04583-2. Epub 2019 Nov 27. Erratum in: Eur J Nucl Med Mol Imaging. 2019 Dec 20;:.

PMID:
31776632
4.

Preservation of erectile function by artery sparing dilation of the corpora cavernosa in prolonged priapism.

Stuehmeier J, Pedrini M, Horninger W, Rehder P.

Urol Case Rep. 2019 Mar 26;24:100882. doi: 10.1016/j.eucr.2019.100882. eCollection 2019 May.

5.

Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival.

Lindner AK, Schachtner G, Steiner E, Kroiss A, Uprimny C, Steinkohl F, Horninger W, Heidegger I, Madersbacher S, Pichler R.

World J Urol. 2020 Feb;38(2):417-424. doi: 10.1007/s00345-019-02793-9. Epub 2019 May 6.

6.

Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature.

Pircher A, Schäfer G, Eigentler A, Pichler R, Puhr M, Steiner E, Horninger W, Gunsilius E, Klocker H, Heidegger I.

Int J Med Sci. 2019 Jan 1;16(1):115-124. doi: 10.7150/ijms.28735. eCollection 2019.

7.

ASCO 2018: highlights of urothelial cancer and prostate cancer.

Pichler R, Horninger W, Heidegger I.

Memo. 2018;11(4):284-290. doi: 10.1007/s12254-018-0422-0. Epub 2018 Jul 24. Review.

8.

Immune-related lichenoid mucocutaneous erosions during anti-PD-1 immunotherapy in metastatic renal cell carcinoma - A case report.

Lindner AK, Schachtner G, Tulchiner G, Staudacher N, Steinkohl F, Nguyen VA, Horninger W, Pichler R.

Urol Case Rep. 2018 Nov 15;23:1-2. doi: 10.1016/j.eucr.2018.11.008. eCollection 2019 Mar. No abstract available.

9.

[Symptomatic urinary obstruction in patients with metastatic malignancies].

Heidegger I, Steinkohl F, Horninger W, Pichler R.

Aktuelle Urol. 2018 Sep;49(5):422-428. doi: 10.1055/a-0658-0790. Epub 2018 Sep 5. Review. German.

PMID:
30184601
10.

Antidiabetic drugs influence molecular mechanisms in prostate cancer.

Pircher A, Zieher M, Eigentler A, Pichler R, Schäfer G, Fritz J, Puhr M, Steiner E, Horninger W, Klocker H, Heidegger I.

Cancer Biol Ther. 2018;19(12):1153-1161. doi: 10.1080/15384047.2018.1491490. Epub 2018 Aug 1.

11.

Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients.

Pichler R, Fritz J, Lackner F, Sprung S, Brunner A, Horninger W, Loidl W, Pircher A, Heidegger I.

Clin Genitourin Cancer. 2018 Oct;16(5):e1015-e1024. doi: 10.1016/j.clgc.2018.05.015. Epub 2018 Jun 8.

PMID:
29960831
12.

Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.

Uprimny C, Svirydenka A, Fritz J, Kroiss AS, Nilica B, Decristoforo C, Haubner R, von Guggenberg E, Buxbaum S, Horninger W, Virgolini IJ.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1873-1883. doi: 10.1007/s00259-018-4048-6. Epub 2018 May 16.

PMID:
29766246
13.

Ten years of intraoperative floppy iris syndrome in the era of α-blockers.

Lunacek A, Mohamad Al-Ali B, Radmayr C, Weber M, Horninger W, Findl O, Plas E.

Cent European J Urol. 2018;71(1):98-104. doi: 10.5173/ceju.2017.1234. Epub 2017 Dec 6. Review.

14.

Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer.

Urbiola C, Santer FR, Petersson M, van der Pluijm G, Horninger W, Erlmann P, Wollmann G, Kimpel J, Culig Z, von Laer D.

Int J Cancer. 2018 Oct 1;143(7):1786-1796. doi: 10.1002/ijc.31556. Epub 2018 Jul 3.

15.

Differential clinical presentation of Adamantiades-Behçet's disease in non-endemic and endemic areas: retrospective data from a Middle-European cohort study.

Moosmann T, Veraar C, Brunner J, Fraedrich G, Frech A, Horninger W, Ratzinger G, Streif W, Teuchner B, Willeit J, Zlamy M, De Zordo T, Schirmer M.

Int J Rheum Dis. 2018 Dec;21(12):2151-2157. doi: 10.1111/1756-185X.13306. Epub 2018 Apr 17.

16.

Radium-223 for metastatic castration-resistant prostate cancer: results and remaining open issues after the ALSYMPCA trial.

Heidegger I, Pichler R, Heidenreich A, Horninger W, Pircher A.

Transl Androl Urol. 2018 Mar;7(Suppl 1):S132-S134. doi: 10.21037/tau.2017.10.06. No abstract available.

17.

Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients.

Lieb V, Weigelt K, Scheinost L, Fischer K, Greither T, Marcou M, Theil G, Klocker H, Holzhausen HJ, Lai X, Vera J, Ekici AB, Horninger W, Fornara P, Wullich B, Taubert H, Wach S.

Oncotarget. 2017 Dec 30;9(12):10402-10416. doi: 10.18632/oncotarget.23781. eCollection 2018 Feb 13.

18.

High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma.

Seeber A, Klinglmair G, Fritz J, Steinkohl F, Zimmer KC, Aigner F, Horninger W, Gastl G, Zelger B, Brunner A, Pichler R.

Cancer Sci. 2018 May;109(5):1583-1591. doi: 10.1111/cas.13560. Epub 2018 Apr 16.

19.

Abstracts of the 33rd International Austrian Winter Symposium : Zell am See, Austria. 24-27 January 2018.

Binzel K, Adelaja A, Wright CL, Scharre D, Zhang J, Knopp MV, Teoh EJ, Bottomley D, Scarsbrook A, Payne H, Afaq A, Bomanji J, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Chau A, Ward P, Miller MP, Stevens DJ, Wilson L, Gleeson FV, Scheidhauer K, Seidl C, Autenrieth M, Bruchertseifer F, Apostolidis C, Kurtz F, Horn T, Pfob C, Schwaiger M, Gschwend J, D'Alessandria C, Morgenstern A, Uprimny C, Kroiss A, Decristoforo C, von Guggenberg E, Nilica B, Horninger W, Virgolini I, Rasul S, Poetsch N, Woehrer A, Preusser M, Mitterhauser M, Wadsak W, Widhalm G, Mischkulnig M, Hacker M, Traub-Weidinger T, Wright CL, Binzel K, Wuthrick EJ, Miller ED, Maniawski P, Zhang J, Knopp MV, Rep S, Hocevar M, Vaupotic J, Zdesar U, Zaletel K, Lezaic L, Mairinger S, Filip T, Sauberer M, Flunkert S, Wanek T, Stanek J, Okamura N, Langer O, Kuntner C, Fornito MC, Balzano R, Di Martino V, Cacciaguerra S, Russo G, Seifert D, Kleinova M, Cepa A, Ralis J, Hanc P, Lebeda O, Mosa M, Vandenberghe S, Mikhaylova E, Borys D, Viswanath V, Stockhoff M, Efthimiou N, Caribe P, Van Holen R, Karp JS, Binzel K, Zhang J, Wright CL, Maniawski P, Knopp MV, Haller PM, Farhan C, Piackova E, Jäger B, Knoll P, Kiss A, Podesser BK, Wojta J, Huber K, Mirzaei S, Traxl A, Komposch K, Glitzner E, Wanek T, Mairinger S, Sibilia M, Langer O, Fornito MC, Russello M, Russo G, Balzano R, Sorko S, Gallowitsch HJ, Kohlfuerst S, Matschnig S, Rieser M, Sorschag M, Lind P, Ležaič L, Rep S, Žibert J, Frelih N, Šuštar S, Binzel K, Adelaja A, Wright CL, Scharre D, Zhang J, Knopp MV, Baum RP, Langbein T, Singh A, Shahinfar M, Schuchardt C, Volk GF, Kulkarni HR, Fornito MC, Cacciaguerra S, Balzano R, Di Martino GV, Russo G, Thomson WH, Kudlacek M, Karik M, Farhan C, Rieger H, Pokieser W, Glaser K, Mirzaei S, Petz V, Tugendsam C, Buchinger W, Schmoll-Hauer B, Schenk IP, Rudolph K, Krebs M, Zettinig G, Zoufal V, Wanek T, Krohn M, Mairinger S, Stanek J, Sauberer M, Filip T, Pahnke J, Langer O, Weitzer F, Pernthaler B, Salamon S, Aigner R, Koranda P, Henzlová L, Kamínek M, Váchalová M, Bachleda P, Summer D, Garousi J, Oroujeni M, Mitran B, Andersson KG, Vorobyeva A, Löfblom JN, Orlova A, Tolmachev V, Decristoforo C, Kaeopookum P, Summer D, Orasch T, Lechner B, Petrik M, Novy Z, Rangger C, Haas H, Decristoforo C.

EJNMMI Res. 2018 Jan 23;8(Suppl 1):5. doi: 10.1186/s13550-017-0354-4. No abstract available.

20.

Adenomatoid tumor of the testis mimicking malignant testicular cancer on multiparametric ultrasound.

Pichler R, Tulchiner G, Steinkohl F, Soleiman A, Horninger W, Heidegger IM, Aigner F.

Eur J Med Res. 2018 Jan 11;23(1):3. doi: 10.1186/s40001-018-0301-5.

21.

Gender-related Outcome in Bladder Cancer Patients undergoing Radical Cystectomy.

Pichler R, Fritz J, Heidegger I, Oberaigner W, Horninger W, Hochleitner M.

J Cancer. 2017 Sep 30;8(17):3567-3574. doi: 10.7150/jca.21130. eCollection 2017.

22.

Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.

Pichler R, Fritz J, Tulchiner G, Klinglmair G, Soleiman A, Horninger W, Klocker H, Heidegger I.

BJU Int. 2018 Jan;121(1):29-37. doi: 10.1111/bju.14019. Epub 2017 Oct 12.

23.

Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.

Pichler R, Tulchiner G, Fritz J, Schaefer G, Horninger W, Heidegger I.

Int J Med Sci. 2017 Jul 19;14(9):811-819. doi: 10.7150/ijms.19929. eCollection 2017.

24.

Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model.

Mühlberger N, Boskovic K, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Sroczynski G, Siebert U.

BMC Public Health. 2017 Jun 26;17(1):596. doi: 10.1186/s12889-017-4439-9.

25.

Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.

Uprimny C, Kroiss AS, Fritz J, Decristoforo C, Kendler D, von Guggenberg E, Nilica B, Maffey-Steffan J, di Santo G, Bektic J, Horninger W, Virgolini IJ.

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1647-1655. doi: 10.1007/s00259-017-3743-z. Epub 2017 Jun 6.

PMID:
28589253
26.

Effect of Urinary Cytology for Detecting Recurrence in Remnant Urothelium After Radical Cystectomy: Insights From a 10-year Cytology Database.

Pichler R, Tulchiner G, Oberaigner W, Schaefer G, Horninger W, Brunner A, Heidegger I.

Clin Genitourin Cancer. 2017 Oct;15(5):e783-e791. doi: 10.1016/j.clgc.2017.03.003. Epub 2017 Mar 30.

27.

ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter study.

Heidegger I, Klocker H, Pichler R, Pircher A, Prokop W, Steiner E, Ladurner C, Comploj E, Lunacek A, Djordjevic D, Pycha A, Plas E, Horninger W, Bektic J.

Prostate Cancer Prostatic Dis. 2017 Sep;20(3):271-275. doi: 10.1038/pcan.2017.3. Epub 2017 Mar 21.

PMID:
28322234
28.

68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.

Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, Scarpa L, di Santo G, Roig LG, Maffey-Steffan J, Horninger W, Virgolini IJ.

Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):941-949. doi: 10.1007/s00259-017-3631-6. Epub 2017 Jan 31.

PMID:
28138747
29.

The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates.

Scarpa L, Buxbaum S, Kendler D, Fink K, Bektic J, Gruber L, Decristoforo C, Uprimny C, Lukas P, Horninger W, Virgolini I.

Eur J Nucl Med Mol Imaging. 2017 May;44(5):788-800. doi: 10.1007/s00259-016-3609-9. Epub 2017 Jan 12.

PMID:
28083690
30.

High incidence of clinically significant concomitant prostate cancer in patients undergoing radical cystectomy for bladder cancer: A 10-year single-center experience.

Heidegger I, Oberaigner W, Horninger W, Pichler R.

Urol Oncol. 2017 Apr;35(4):152.e1-152.e5. doi: 10.1016/j.urolonc.2016.11.004. Epub 2016 Dec 10.

PMID:
27956007
31.

Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.

Uprimny C, Kroiss AS, Decristoforo C, Fritz J, Warwitz B, Scarpa L, Roig LG, Kendler D, von Guggenberg E, Bektic J, Horninger W, Virgolini IJ.

Eur J Nucl Med Mol Imaging. 2017 May;44(5):765-775. doi: 10.1007/s00259-016-3578-z. Epub 2016 Nov 29.

PMID:
27900519
32.

Long term disease free survival with multimodal therapy in small cell bladder cancer.

Heidegger I, Tulchiner G, Schäfer G, Horninger W, Pichler R.

Eur J Med Res. 2016 Oct 13;21(1):40.

33.

Pelvic Lymph Node Staging by Combined 18F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy.

Pichler R, De Zordo T, Fritz J, Kroiss A, Aigner F, Heidegger I, Virgolini I, Horninger W, Uprimny C.

Clin Genitourin Cancer. 2017 Jun;15(3):e387-e395. doi: 10.1016/j.clgc.2016.08.009. Epub 2016 Aug 10.

PMID:
27601364
34.

Paratesticular Metastasis of a Clear-Cell Renal-Cell Carcinoma With Renal Vein Thrombus Mimicking Primary Testicular Cancer.

Pichler R, Tulchiner G, Aigner F, Horninger W, Heidegger I.

Clin Genitourin Cancer. 2017 Feb;15(1):e123-e126. doi: 10.1016/j.clgc.2016.06.016. Epub 2016 Jun 29. No abstract available.

PMID:
27450513
35.

Evaluation of Mathisen's technique for ureteral reimplantation in children with primary vesicoureteral reflux.

Haid B, Strasser C, Becker T, Koen M, Berger C, Roesch J, Stuehmeier J, Schlenck B, Horninger W, Oswald J.

J Pediatr Urol. 2016 Dec;12(6):393.e1-393.e7. doi: 10.1016/j.jpurol.2016.04.043. Epub 2016 Jul 7.

PMID:
27430662
36.

[Multiparametric US of the Testicles--Selected Cases].

Auer T, De Zordo T, Horninger W, Jaschke W, Aigner F.

Rofo. 2016 Apr;188(4):331-5. doi: 10.1055/s-0041-110806. Epub 2016 Apr 6. German. No abstract available.

PMID:
27050539
37.

Hypothesis That Urethral Bulb (Corpus Spongiosum) Plays an Active Role in Male Urinary Continence.

Rehder P, Staudacher NM, Schachtner J, Berger ME, Schillfahrt F, Hauser V, Mueller R, Skradski V, Horninger W, Glodny B.

Adv Urol. 2016;2016:6054730. doi: 10.1155/2016/6054730. Epub 2016 Jan 31. Review.

38.

[Bevacizumab as first-line therapy in metastatic renal cell carcinoma: Progression-free survival for 3 years].

Pichler R, Horninger W, Aigner F, Heidegger I.

Urologe A. 2016 Mar;55(3):381-5. doi: 10.1007/s00120-015-3976-z. German.

PMID:
26471795
39.

Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?

Heidegger I, Höfer J, Luger M, Pichler R, Klocker H, Horninger W, Steiner E, Jochberger S, Culig Z.

Prostate. 2015 Dec;75(16):1904-9. doi: 10.1002/pros.23086. Epub 2015 Aug 26.

PMID:
26306920
40.

Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program.

Heidegger I, Fritz J, Klocker H, Pichler R, Bektic J, Horninger W.

PLoS One. 2015 Jul 28;10(7):e0134134. doi: 10.1371/journal.pone.0134134. eCollection 2015.

41.

PSA Isoforms' Velocities for Early Diagnosis of Prostate Cancer.

Heidegger I, Klocker H, Pichler R, Horninger W, Bektic J.

Anticancer Res. 2015 Jun;35(6):3567-70.

PMID:
26026127
42.

The ONCOTYROL Prostate Cancer Outcome and Policy Model: Effect of Prevalence Assumptions on the Benefit-Harm Balance of Screening.

Mühlberger N, Kurzthaler C, Iskandar R, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Conrads-Frank A, Sroczynski G, Siebert U.

Med Decis Making. 2015 Aug;35(6):758-72. doi: 10.1177/0272989X15585114. Epub 2015 May 14.

PMID:
25977360
43.

(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?

Ceci F, Uprimny C, Nilica B, Geraldo L, Kendler D, Kroiss A, Bektic J, Horninger W, Lukas P, Decristoforo C, Castellucci P, Fanti S, Virgolini IJ.

Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1284-94. doi: 10.1007/s00259-015-3078-6. Epub 2015 May 15.

PMID:
25975367
44.

Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot.

Pichler R, Borena W, Schäfer G, Manzl C, Culig Z, List S, Neururer S, Von Laer D, Heidegger I, Klocker H, Horninger W, Steiner H, Brunner A.

World J Urol. 2015 Dec;33(12):2145-51. doi: 10.1007/s00345-015-1539-y. Epub 2015 Mar 19.

PMID:
25786709
45.

Patient-reported urinary incontinence and erectile dysfunction following radical prostatectomy: results from the European Prostate Centre Innsbruck.

Geiger-Gritsch S, Oberaigner W, Mühlberger N, Siebert U, Ladurner M, Klocker H, Horninger W.

Urol Int. 2015;94(4):419-27. doi: 10.1159/000369475. Epub 2015 Jan 31.

PMID:
25662301
46.

High risk of under-grading and -staging in prostate cancer patients eligible for active surveillance.

Heidegger I, Skradski V, Steiner E, Klocker H, Pichler R, Pircher A, Horninger W, Bektic J.

PLoS One. 2015 Feb 6;10(2):e0115537. doi: 10.1371/journal.pone.0115537. eCollection 2015.

47.

The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening.

Mühlberger N, Heijnsdijk EA, Kurzthaler C, Iskandar R, Krahn MD, Bremner K, Oberaigner W, Klocker H, Horninger W, Conrads-Frank A, Sroczynski G, Siebert U.

Value Health. 2014 Nov;17(7):A559. doi: 10.1016/j.jval.2014.08.1843. Epub 2014 Oct 26. No abstract available.

48.

(68)Ga-PSMA ligand PET versus (18)F-NaF PET: evaluation of response to (223)Ra therapy in a prostate cancer patient.

Uprimny C, Kroiss A, Nilica B, Buxbaum S, Decristoforo C, Horninger W, Virgolini IJ.

Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):362-3. doi: 10.1007/s00259-014-2922-4. Epub 2014 Oct 8. No abstract available.

PMID:
25293866
49.

Pfannenstiel incision for radical retropubic prostatectomy as a surgical and cosmetic alternative to the midline or laparoscopic approach: A single center study.

Lunacek A, Radmayr C, Horninger W, Plas E.

Cent European J Urol. 2014;67(2):149-52. doi: 10.5173/ceju.2014.02.art6. Epub 2014 Jun 23.

50.

De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound.

Pichler R, Heidegger I, Aigner F, Bösmüller C, Schneeberger S, Maglione M, Schäfer G, Steiner H, Horninger W.

Urol Int. 2014;93(3):364-7. doi: 10.1159/000362422. Epub 2014 Aug 12.

PMID:
25115614

Supplemental Content

Loading ...
Support Center